Everus Construction Group (ECG) Financials

Everus Construction Group (NYSE: ECG) is showing strong operating momentum through the second quarter of 2026. The company’s latest results point to accelerating revenue, expanding margins and higher earnings, although cash declined sharply during the quarter because of significant investing activity and working-capital needs.

• Revenue growth has accelerated. Q2 2026 revenue reached $1.23 billion, up 33.7% from $921.5 million in Q2 2025. Revenue has also increased sequentially from $1.04 billion in Q1 2026 and has generally trended higher from $717.4 million in Q3 2023 and $760.985 million in Q3 2024.
• Gross profitability is improving. Gross profit rose 52.6% year over year to $182.9 million in Q2 2026. The gross margin expanded to approximately 14.9%, compared with 13.0% in Q2 2025 and 11.8% in Q3 2023.
• Operating income is growing faster than sales. Q2 2026 operating income increased 54.2% year over year to $111.8 million, while the operating margin improved to about 9.1% from 7.9% in Q2 2025. This suggests the company is benefiting from operating leverage despite higher selling, general and administrative expenses.
• Net income and EPS continue to rise. Net income increased 58.7% year over year to $83.9 million in Q2 2026. Diluted EPS climbed to $1.64 from $1.03 in Q2 2025, extending a broader improvement from $0.71 in Q3 2023 and $0.82 in Q3 2024.
• Operating cash flow improved substantially year over year. Cash flow from operations was $53.1 million in Q2 2026, more than double the $25.3 million generated in Q2 2025. Operating cash flow was also positive in each reported quarter, although it fluctuated considerably.
• Debt levels remain manageable. Total short- and long-term debt was approximately $274.5 million at the end of Q2 2026, down from $288.6 million a year earlier. The company also repaid $3.75 million of debt in each of the latest reported quarters.
• Shareholders’ equity has expanded. Total equity increased to $773.2 million in Q2 2026 from $514.4 million in Q2 2025, supported primarily by higher retained earnings. This improved the balance sheet’s equity cushion and reduced debt relative to equity.
• Liquidity is adequate but has weakened sequentially. Current assets of $1.48 billion exceeded current liabilities of $930.2 million, implying a current ratio of roughly 1.6. However, cash fell to $176.7 million from $293.4 million at the end of Q1 2026, even though it remained well above the $84.7 million reported at the end of Q2 2025.
• Accounts receivable is becoming a larger use of capital. Accounts receivable rose to $919.2 million in Q2 2026 from $683.0 million a year earlier, broadly in line with revenue growth but still representing a substantial portion of current assets. Investors should monitor collections and contract billing as the business expands.
• Q2 cash flow was pressured by investing activity and working capital. Net cash declined by $116.7 million during Q2 2026, compared with a $10.7 million increase in Q2 2025. Investing cash flow was negative $165.9 million, far greater than the prior-year outflow, while changes in operating assets and liabilities used $81.7 million of cash.

Overall assessment: ECG’s income statement shows a favorable multi-quarter trend, with revenue growth translating into faster growth in operating income, net income and EPS. The main concern is cash conversion: rising accounts receivable and a large second-quarter investing outflow caused cash to fall sharply. The balance sheet remains solid for now, but investors should determine whether the investing outflow represents a productive acquisition or expansion investment and whether working-capital demands moderate in future quarters.